Stocks · News reference

Kazia Therapeutics shares are trading lower after the company announced pricing of up to $120 million public offering.

Aug 28, 2026, 2:25 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

BenzingaAug 28, 2026, 11:32 AMBenzinga Newsdesk
Kazia Therapeutics Prices ~$40M Offering Of 2.58M American Depositary Shares At $17.825 Per ADS
Kazia Therapeutics Limited (NASDAQ:KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity
Read original at benzinga
KZIA
BenzingaAug 27, 2026, 8:18 PMBenzinga Newsdesk
Kazia Therapeutics shares are trading lower after the company announced a proposed public offering.
Read original at benzinga
KZIA
BenzingaAug 27, 2026, 8:13 PMBenzinga Newsdesk
Kazia Therapeutics Commences Offering Of American Depositary Shares; Terms Undisclosed
Kazia Therapeutics Limited (NASDAQ:KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity
Read original at benzinga
KZIA